Google Übersetzer
Voyager Therapeutics, Inc.
About
Voyager Therapeutics, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
May 7 2026
Voyager Reports First Quarter 2026 Financial and Operating Results
Apr 27 2026
Voyager IV-Delivered CNS Gene Therapies Featured in Multiple Presentations at ASGCT 2026, Including Late Breaker on Tau-Targeted VY1706 for Alzheimer’s Disease
Mar 9 2026
Voyager Reports Fourth Quarter and Full Year 2025 Financial and Operating Results
Feb 9 2026
Voyager to Present at Upcoming Investor Conferences
Nov 10 2025
Transition Bio and Voyager Announce Collaboration to Advance Small Molecules Targeting TDP-43 in ALS and Frontotemporal Dementia